Denali Therapeutics Inc (DNLI)

Other Income/Expenses (Net)

$2.99M

Quarterly · Period ending: · USD

DNLI logo

DNLI Other Income/Expenses (Net)

Latest reported$2.99M
DNLI Quarterly Other Income/Expenses (Net) ($19.00K → $2.99M)
High-resolution chart · PNG

DNLI other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Denali Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
2,988,000
8,910,000
8,918,000
10,532,000
10,844,000
12,610,000
15,161,000
15,995,000
17,567,000
15,913,000
13,129,000
14,442,000
12,900,000
11,034,000
6,660,000
4,187,000
2,649,000
1,278,000
1,285,000
1,005,000
1,126,000
1,179,000
1,630,000
1,944,000
2,598,000
3,069,000
3,808,000
3,782,000
4,113,000
3,516,000
2,811,000
2,593,000
2,658,000
2,070,000
653,000
444,000
434,000
424,000
512,000
231,000
19,000
19,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.